The board of directors of Lijun International Pharmaceutical (Holding) Co Ltd. announced that the group is expected to record a significant increase in the amount of net profit for the six months ended June 30, 2013 as compared to the amount of net profit for the six months ended June 30, 2012. This significant increase in the amount of net profit is primarily attributable to significant growth of the intravenous infusion solution business of the group in the six months ended June 30, 2013.